13 hrs ago
Kaiser Permanente signs up for Cxbladder
Pacific Edge Ltd has signed an agreement with Southern California Permanente Medical Group to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente's health care network.
17 hrs ago
Cardinal George cancels trip to Rome so he can receive cancer treatment
Cardinal Francis George will miss a planned trip to Rome in October to instead receive treatment for cancer, the Archdiocese of Chicago said Tuesday.
New tool to probe cancer's molecular make-up
Scientists have shown how to better identify and measure vital molecules that control cell behaviour - paving the way for improved tools for diagnosis, prediction and monitoring of cancer.
Mon Aug 25, 2014
Cardinal George participating in clinical trial of anti-cancer drug
Chicago, Ill., Aug 25, 2014 / 10:46 am .- Cardinal Francis George of Chicago is continuing cancer treatment and has agreed to take part in a clinical trial of a new anti-cancer drug, his archdiocese has announced.
Applied Clinical Trials
Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a ...
This new PD-L1 clone was developed for Roche/Genentech's anti-PD-L1 immunotherapy development program.
Fri Aug 22, 2014
Cardinal George testing new cancer drug
Cardinal Francis George, facing his third bout with cancer, is participating in a clinical trial of a new drug being conducted at the University of Chicago, the archdiocese announced Friday.
Thu Aug 21, 2014
Building Presence in World's Largest Biomedical Market
At its annual shareholders' meeting held yesterday in Dunedin, New Zealand, cancer diagnostic developer, Pacific Edge, celebrated the commercial launch of its flagship bladder cancer diagnostic product, Cxbladder, into the US and provided shareholders with an update on its growth plans.
Surgery associated with better survival for patients with advanced laryngeal cancer
Approximately 11,000 to 13,000 cases of laryngeal cancer are diagnosed each year and squamous cell carcinoma accounts for the vast majority of these tumors.
Arutz Sheva Israel News
Technology & HealthWoman's Cancer Drives Daughter to Research Breakthrough
Dr. Svetlana Bunimovich, lecturer in the Department of Computer Science and Mathematics at the University of Ariel, will present research done using mathematical models, to improve the treatment of bladder cancer, at a conference to be held at Ariel University next week .
Wed Aug 20, 2014
Validation of RiskCheck Bladder Cancera OEA , version 5.0 for...
The aim of the study was to assess the strength of the online tool RiskCheck Bladder CancerA©, version 5.0 for early detection of bladder cancer .
Largest cancer genomic study proposes 'disruptive' new system to reclassify tumors
TCGA scientists analyzed the DNA, RNA and protein from 12 different tumor types using six different TCGA "platform technologies" to see how the different tumor types compare to each other.
Tue Aug 19, 2014
Revealed: The most devastating failures by public services
Paul Gallagher is a reporter for the Independent and Independent on Sunday having joined the group in 2012.
Bioniche Life Sciences Inc. Announces Q1/2015 Timeline For The Filing ...
This projected timeline integrates the conclusions of a regulatory gap analysis prepared by its consultants with the planning and scheduling of a pre-BLA meeting between Bioniche and the FDA prior to the BLA filing.
Customer Interaction Solutions
Altor BioScience Awarded SBIR Phase II Grant by NCI for Clinical...
Altor BioScience Corporation , a leading developer of cancer immunotherapies, announced today that it has been awarded a Small Business Innovation Research Phase II grant by the National Cancer Institute for the clinical development of ALT-803, a proprietary interleukin-15 superagonist protein complex, against non-muscle invasive bladder cancer .
Sat Aug 16, 2014
Market Report, "Marina Biotech, Inc. (MRNA) - Pharmaceuticals &...
It develops and commercializes therapeutic products based on RNS interference and mRNA translational blocking.
Thu Aug 14, 2014
Father of newborn son struggling with aggressive cancer battle
A Northampton County dad needs your help. Just weeks after his son was born, he found out he has a rare and aggressive cancer.
Wed Aug 13, 2014
Could Hyaluronic acid (HA) reduce Bacillus Calmette-Guerin (BCG)...
Bacillus Calmette-Guerin is considered the most effective treatment to reduce recurrence and progression of non-muscle invasive bladder cancer but can induce local side effects leading to treatment discontinuation or interruption.
Tengion says regenerative kidney treatment trial on track
Tengion , the Winston-Salem biotech company working to commercialize some of the technologies developed by Dr. Anthony Atala and the Wake Forest Institute for Regenerative Medicine , said the Phase 1 clinical trial of its Neo-Kidney Augment is on track so far.
Clinical trial tests COXEN model to predict best treatment for bladder cancer
Imagine being able to match a cancer's genes to the best treatment. That's the promise of COXEN - a computer program that looks at a panel of cancer genes in a patient's tumor to predict whether it will respond to chemotherapy.
Tue Aug 12, 2014
New Albany Gazette
Bladder surgery and a priest
Jenny was prepared for the worst when she was wheeled into her room after bladder surgery at Baptist Memorial Hospital in Oxford and was met by a priest.